DHR

Danaher Corporation
NYSE
Price 8/8 1:21 AM (ET)
$204.19
$ Change
+4.21
% Change
+2.11%
Latest News
10 items
Seeking Alpha Neutral 8/7 1:10 AM
Diamond Hill Small-Mid Cap Fund Q2 2026 Portfolio Review

The Fund increased 9.71% compared to a 20.26% increase for the Russell 2500 Index. We initiated a position in managed care provider Centene. Shares of website design software provider Wix.com were sold as the company's core business has experienced slowing growth due to AI-driven vibe coding.

Seeking Alpha Neutral 8/6 7:29 PM
Aristotle Value Equity WM Q2 2026 Portfolio Performance

For the second quarter of 2026, Aristotle Capital's Value Equity WM Composite posted a total return of 4.36% pure gross of fees (3.85% net of fees). Corteva, the seed and crop protection company, was one of the largest detractors during the period. Motorola Solutions, the provider of mission-critical communications and security systems, was one of the largest detractors during the quarter.

PRNewsWire Neutral 8/3 8:15 PM
Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer

Rainer Blair to retire WASHINGTON, Aug. 3, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a senior advisor until March 31, 2027 to ensure a seamless transition.

Seeking Alpha Neutral 7/30 5:20 AM
Aristotle Global Equity Advisory Q2 2026 Portfolio Review

For the second quarter of 2026, Aristotle Capital's Global Equity WM Composite posted a total return of 6.92% pure gross of fees (6.40% net of fees), underperforming the MSCI ACWI Index, which returned 14.93%, and the MSCI World Index, which returned 13.76%. During the quarter, we sold our positions in Danaher, Dolby Laboratories, and Tokyo Century and purchased Techtronic Industries and Wal-Mart de Mexico. Munich Re, the world's largest reinsurance company, was a detractor during the quarter.

Benzinga Negative 7/22 8:09 PM
Stock Of The Day: Is The Danaher Selloff Over?

Danaher Corporation  (NYSE:DHR) is consolidating on Wednesday. The shares plunged by more than 10% yesterday, with the move driven by a weak earnings report.

Zacks Investment Research Positive 7/22 2:56 PM
Can Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Danaher (DHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Market Cap
143.94B
Dol. Volume
678.70M
Volume
3.32M
52W Range
$160.93 - $242.8
1 Week
+4.72%
1 Month
+4.19%
1 Year
+1.81%
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.